EAR - Eargo, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Eargo, Inc.

2665 North First Street
Suite 300
San Jose, CA 95134
United States
650 351 7700

IndustryMedical Devices
Full-time employees243

Key executives

NameTitlePayExercisedYear born
Mr. Christian GormsenCEO, Pres & Director991.2kN/A1977
Mr. Adam LaponisChief Financial Officer586.2kN/A1976
Mr. William H. BrownieChief Operating Officer625.2kN/A1967
Mr. Daniel ShenCo-Founder and Chief Clinical & Science OfficerN/AN/AN/A
Mr. Mark ThorpeChief Accounting OfficerN/AN/A1968
Mr. Tim Trine Ph.D.Chief Technology OfficerN/AN/AN/A
Ms. Christy La PierreChief Legal Officer & Sec.N/AN/AN/A
Mr. Frederick D. Knight CCEP, M.B.A.Chief Compliance OfficerN/AN/AN/A
Mr. Pio SchunkerChief Marketing OfficerN/AN/AN/A
Ms. Tricia BurchellVP of People Operations & TalentN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.

Corporate governance

Eargo, Inc.’s ISS governance QualityScore as of 1 June 2023 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.